Literature DB >> 15004700

Trichomonas vaginalis degrades nitric oxide and expresses a flavorubredoxin-like protein: a new pathogenic mechanism?

P Sarti1, P L Fiori2, E Forte3, P Rappelli2, M Teixeira4, D Mastronicola3, G Sanciu2, A Giuffré3, M Brunori3.   

Abstract

Besides possessing many physiological roles, nitric oxide (NO) produced by the immune system in infectious diseases has antimicrobial effects. Trichomoniasis, the most widespread non-viral sexually transmitted disease caused by the microaerophilic protist Trichomonas vaginalis, often evolves into a chronic infection, with the parasite able to survive in the microaerobic, NO-enriched vaginal environment. We relate this property to the finding that T. vaginalis degrades NO under anaerobic conditions, as assessed amperometrically. This activity, which is maximal (133 +/- 41 nmol NO/10(8) cells per minute at 20 degrees C) at low NO concentrations (< or = 1.2 microM), was found to be: (i) NADH dependent, (ii) cyanide insensitive and (iii) inhibited by O(2). These features are consistent with those of the Escherichia coli A-type flavoprotein (ATF), recently discovered to be endowed with NO reductase activity. Using antibodies against the ATF from E. coli, a protein band was immunodetected in the parasite grown in a standard medium. If confirmed, the expression of an ATF in eukaryotes suggests that the genes coding for ATFs were transferred during evolution from anaerobic Prokarya to pathogenic protists, to increase their fitness for the microaerobic, parasitic life style. Thus the demonstration of an ATF in T. vaginalis would appear relevant to both pathology and evolutionary biology. Interestingly, genomic analysis has recently demonstrated that Giardia intestinalis and other pathogenic protists have genes coding for ATFs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004700     DOI: 10.1007/s00018-003-3413-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  8 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

2.  Sympathectomy in the treatment of hypertension; review of 122 cases.

Authors:  D M MORRISSEY; V S BROOKES; W T COOKE
Journal:  Lancet       Date:  1953-02-28       Impact factor: 79.321

Review 3.  Physiology in perspective: The Wisdom of the Body. Neural control of the kidney.

Authors:  Gerald F DiBona
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09       Impact factor: 3.619

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 5.  Renal nerves in the maintenance of hypertension: a potential therapeutic target.

Authors:  Richard E Katholi; Krishna J Rocha-Singh; Nilesh J Goswami; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-06       Impact factor: 5.369

6.  Relationship between central sympathetic activity and stages of human hypertension.

Authors:  Paul A Smith; Lee N Graham; Alan F Mackintosh; John B Stoker; David A S G Mary
Journal:  Am J Hypertens       Date:  2004-03       Impact factor: 2.689

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

  8 in total
  15 in total

1.  A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.

Authors:  Haris Mirza; Zhaona Wu; Fahad Kidwai; Kevin S W Tan
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Dioxygen and nitric oxide scavenging by Treponema denticola flavodiiron protein: a mechanistic paradigm for catalysis.

Authors:  Rosanne E Frederick; Jonathan D Caranto; Cesar A Masitas; Linda L Gebhardt; Charles E MacGowan; Ronald J Limberger; Donald M Kurtz
Journal:  J Biol Inorg Chem       Date:  2015-02-21       Impact factor: 3.358

3.  Neuroglobin, nitric oxide, and oxygen: functional pathways and conformational changes.

Authors:  Maurizio Brunori; Alessandro Giuffrè; Karin Nienhaus; G Ulrich Nienhaus; Francesca Maria Scandurra; Beatrice Vallone
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-02       Impact factor: 11.205

4.  Intrinsic susceptibility of Giardia duodenalis assemblage subtypes A(I), A(II), B and E(III) for nitric oxide under axenic culture conditions.

Authors:  Ely Bénéré; Tim Van Assche; Paul Cos; Louis Maes
Journal:  Parasitol Res       Date:  2011-09-06       Impact factor: 2.289

5.  Synthesis and characterization of a model complex for flavodiiron NO reductases that stabilizes a diiron mononitrosyl complex.

Authors:  Hai T Dong; Yu Zong; Abigail J Bracken; Michael O Lengel; Jeff W Kampf; Debangsu Sil; Carsten Krebs; Nicolai Lehnert
Journal:  J Inorg Biochem       Date:  2022-01-11       Impact factor: 4.155

6.  Desulfovibrio gigas flavodiiron protein affords protection against nitrosative stress in vivo.

Authors:  Rute Rodrigues; João B Vicente; Rute Félix; Solange Oliveira; Miguel Teixeira; Claudina Rodrigues-Pousada
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

7.  Flavodiiron protein from Trichomonas vaginalis hydrogenosomes: the terminal oxygen reductase.

Authors:  Tamara Smutná; Vera L Gonçalves; Lígia M Saraiva; Jan Tachezy; Miguel Teixeira; Ivan Hrdy
Journal:  Eukaryot Cell       Date:  2008-11-14

8.  Entamoeba histolytica modulates a complex repertoire of novel genes in response to oxidative and nitrosative stresses: implications for amebic pathogenesis.

Authors:  João B Vicente; Gretchen M Ehrenkaufer; Lígia M Saraiva; Miguel Teixeira; Upinder Singh
Journal:  Cell Microbiol       Date:  2008-09-05       Impact factor: 3.715

9.  Novel functions of an iron-sulfur flavoprotein from Trichomonas vaginalis hydrogenosomes.

Authors:  Tamara Smutná; Katerina Pilarová; Ján Tarábek; Jan Tachezy; Ivan Hrdý
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

10.  Non-heme mononitrosyldiiron complexes: importance of iron oxidation state in controlling the nature of the nitrosylated products.

Authors:  Amit Majumdar; Stephen J Lippard
Journal:  Inorg Chem       Date:  2013-11-18       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.